← All organizations
Highest phase reached
Phase 3
First clinical trial
Sep 29, 2018Last known activity
Dec 10, 2025
Timeline
2010s
- Jun 1, 2015
Revolution Medicines, Inc.— Founded
2020s
- Nov 9, 2023
EQRx, Inc.— Acquired
Drugs by trial phase (32 distinct, 21 trials)
Phase 3 (8 own, 4 via acquisition)
Phase 2 (16 own, 1 via acquisition)
Other trials (0 own, 1 via acquisition)
Indications
Studied for
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (25)
- NCT07252232Lead sponsorPhase 3Dec 10, 2025
- NCT06922591CollaboratorPhase 1/Phase 2May 31, 2025
- NCT06881784Lead sponsorPhase 3May 6, 2025
- NCT06625320Lead sponsorPhase 3Oct 16, 2024
- NCT06625320OfficialPhase 3Oct 16, 2024
- NCT06445062Lead sponsorPhase 1/Phase 2May 24, 2024
- NCT06445062OfficialPhase 1/Phase 2May 24, 2024
- NCT06162221OfficialPhase 1/Phase 2Dec 31, 2023
- NCT06162221Lead sponsorPhase 1/Phase 2Dec 31, 2023
- NCT06040541Study directorPhase 1Sep 7, 2023
- NCT06040541Lead sponsorPhase 1Sep 7, 2023
- NCT05557292CollaboratorPhase 1Feb 1, 2023
- NCT05462717Study directorPhase 1Sep 19, 2022
- NCT05462717Lead sponsorPhase 1Sep 19, 2022
- NCT05379985Lead sponsorPhase 1May 31, 2022
Details
- Founded
- Redwood City, CA, US Jun 1, 2015
- Last known activity
- Dec 10, 2025